当前位置:
X-MOL 学术
›
Cancer Treat. Rev.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Adding interferon-alpha to octreotide slows tumour progression compared with octreotide alone but evidence is lacking for improved survival in people with disseminated midgut carcinoid tumours.
Cancer Treatment Reviews ( IF 11.8 ) Pub Date : 2003-10-31 , DOI: 10.1016/j.ctrv.2003.07.002 Ulrich Frank Pape 1 , Bertram Wiedenmann
中文翻译:
与仅使用奥曲肽相比,在奥曲肽中添加干扰素-α会减慢肿瘤的进展,但缺乏弥散性中肠类癌患者生存率提高的证据。
更新日期:2019-11-01
Cancer Treatment Reviews ( IF 11.8 ) Pub Date : 2003-10-31 , DOI: 10.1016/j.ctrv.2003.07.002 Ulrich Frank Pape 1 , Bertram Wiedenmann
Affiliation
中文翻译:
与仅使用奥曲肽相比,在奥曲肽中添加干扰素-α会减慢肿瘤的进展,但缺乏弥散性中肠类癌患者生存率提高的证据。